There is no registered clinical trial of the BPC-157 + TB-500 combination , so no combination safety profile exists in humans
A, B and C arms) such as ABC, ACB, BAC, BCA, CAB, or CBA
Studies suggest that caffeine may accelerate the breakdown of collagen in the body
Composition GHK-Cu: 50 mg KPV: 10 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of four co-formulated peptides Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
The transition from M1 (demolition) to M2 (rebuilding) is the most critical turning point in healing
Storage conditions must be adhered to maintain the peptide in its purified, stable state and avoid peptide degradation